[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367478-105":59,"doc-detail-367478-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","multi-omics-analysis-and-experiments-uncover-the-link-between-cancer-intrinsic-drivers-stemness-and-immunotherapy-in-ovarian-cancer-with-validation-in-a-pan-cancer-census","Multi-omics analysis and experiments uncover the link between cancer intrinsic drivers, stemness, and immunotherapy in ovarian cancer with validation in a pan-cancer census","","Although immune checkpoint inhibitors (ICIs) benefit only a subset of patients, cancer heterogeneity and stemness can make responses to immunotherapy variable. This study analyzes ovarian cancer multi-omics single-cell RNA and genome-scale CRISPR screening data to identify intrinsic driver genes and build a cancer stem cell index (CSCI). Using multiple computational algorithms and large cohorts, CSCI is evaluated for prognosis and immunotherapy response with independent validation. Experiments further test functional effects of CSE1L on tumor progression.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-analysis-and-experiments-uncover-the-link-between-cancer-intrinsic-drivers-stemness-and-immunotherapy-in-ovarian-cancer-with-validation-in-a-pan-cancer-census/367478/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-analysis-and-experiments-uncover-the-link-between-cancer-intrinsic-drivers-stemness-and-immunotherapy-in-ovarian-cancer-with-validation-in-a-pan-cancer-census/367478.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"Why is immunotherapy response variable in ovarian cancer?","Question",{"text":112,"@type":113},"ICIs show limited efficacy across patients, and intrinsic heterogeneity and cancer stemness contribute to inconsistent immunotherapy outcomes, motivating biomarker identification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were intrinsic driver genes and the CSCI developed?",{"text":117,"@type":113},"Intrinsic drivers were inferred from publicly available ovarian cancer single-cell RNA data and essential ovarian-specific genes were identified using genome-scale CRISPR screening from Project Achilles. A cancer stem cell index (CSCI) was then constructed and validated using multiple algorithms, datasets, and clinical features.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the CSCI predict in immunotherapy cohorts?",{"text":121,"@type":113},"In PD-1/PD-L1 ICI transcriptomic cohorts, CSCI consistently predicts tumor progression and immunotherapy benefits, with a mean AUC greater than 0.8, and shows improved performance versus previously established signatures.",{"name":123,"@type":110,"acceptedAnswer":124},"What is the role of CSE1L in this study?",{"text":125,"@type":113},"The study reports that amplification of CSE1L enhances stemness of tumor-initiating cells, facilitates angiogenesis, and supports tumor formation. Experimental validation indicates CSE1L promotes ovarian cancer progression, migration, and proliferation.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},367478,1790520764,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Original Research PUBLISHED 08 May 2025  \nDOI 10.3389/fimmu.2025.1549656  \nOPEN ACCESS  \nEDITED BY  \nLaura Conti,  \nUniversity of Turin, Italy  \nREVIEWED BY  \nBibha Choudhary,  \nInstitute of Bioinformatics and Applied Biotechnology, India  \nAurora Savino,  \nHuman Technopole, Italy  \n*CORRESPONDENCE  \nJie Mei  \n [1379915564@qq.com](1379915564@qq.com)[ ](1379915564@qq.com)Lei Han  \n [hanleimm@126.com](hanleimm@126.com)[ ](hanleimm@126.com)Lingwen Kong  \n [lingwenkong@163.com](lingwenkong@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 21 December 2024  \nACCEPTED 16 April 2025  \nPUBLISHED 08 May 2025  \nCITATION  \nLi Y, Chen C, Ji X, Jiang N, Wang F, Gao X, Chen W, Tang Q, Li Y, Zhang S, Qin G, Xu Y, Wang Y, Kong L, Han L and Mei J (2025) Multi-omics analysis and experiments uncover the link between cancer intrinsic drivers, stemness, and immunotherapy in  \novarian cancer with validation in a pan-cancer census.  \nFront. Immunol. 16:1549656 .  \ndoi: 10.3389/fimmu.2025.1549656  \nCOPYRIGHT  \n© 2025 Li, Chen, Ji, Jiang, Wang, Gao, Chen, Tang, Li, Zhang, Qin, Xu, Wang, Kong, Han and Mei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMulti-omics analysis and experiments uncover the link between cancer intrinsic drivers, stemness, and immunotherapy in ovarian cancer with validation ina pan-cancer census  \nYilin Li 1†, Cen Chen 1†, Xiaoyu Ji 2†, Ningxiao Jiang3, Fei Wang 4, Xiangqian Gao 5, Weiwei Chen 4, Qiang Tang 6, Yan Li 6, Shinan Zhang 3, Gaofeng Qin 7, Yingjiang Xu 8, Yanlin Wang 3, Lingwen Kong 9*, Lei Han 3* and Jie Mei 1*  \n1 Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China, 2 Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China, 3 Department of Reproductive Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou,  \nShandong, China, 4 Medical Research Center, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, Shandong, China, 5 Department of Pathology, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, Shandong, China, 6 Meishan City People’s Hospital, Meishan, Sichuan, China, 7 Department of Traditional Chinese Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China, 8 Department of Interventional Vascular Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China, 9 Institute of Intergrated Traditional Chinese and Western Medicine, Huashan Hospital Fudan University, Shanghai, China  \nBackground: Although immune checkpoint inhibitors (ICIs) represent a substantial breakthrough in cancer treatment, it is crucial to acknowledge that their efﬁcacy is limited to a subset of patients. The heterogeneity and stemness of cancer render its response to immunotherapy variable, warranting the identiﬁcation of robust biomarkers for evaluation.  \nMethods: Publicly available Ovarian Cancer (OV) single-cell RNA (scRNA) sequence dataset was collected and analyzed to elucidate the intrinsic driver gene of OV cancer cells. Through genome-scale CRISPR screening of RNA sequencing data from Project Achilles, essential genes speciﬁc to OV were identiﬁed. A novel cancer stem cell index (CSCI) was developed and validated using multiple advanced algorithms and large-scale datasets, as well as corresponding clinical features, including 14 OV transcriptomic datasets, 7 pan-cancer ICI transcriptomic cohorts and one melanoma scRNA dataset derived from PD-1 treated patients.  \n","cbCaiezALSTRKOUE","https://ap.wps.com/l/cbCaiezALSTRKOUE","pdf",10139902,18,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"Why is immunotherapy response variable in ovarian cancer?\",\"answer\":\"ICIs show limited efficacy across patients, and intrinsic heterogeneity and cancer stemness contribute to inconsistent immunotherapy outcomes, motivating biomarker identification.\"},{\"question\":\"How were intrinsic driver genes and the CSCI developed?\",\"answer\":\"Intrinsic drivers were inferred from publicly available ovarian cancer single-cell RNA data and essential ovarian-specific genes were identified using genome-scale CRISPR screening from Project Achilles. A cancer stem cell index (CSCI) was then constructed and validated using multiple algorithms, datasets, and clinical features.\"},{\"question\":\"What does the CSCI predict in immunotherapy cohorts?\",\"answer\":\"In PD-1/PD-L1 ICI transcriptomic cohorts, CSCI consistently predicts tumor progression and immunotherapy benefits, with a mean AUC greater than 0.8, and shows improved performance versus previously established signatures.\"},{\"question\":\"What is the role of CSE1L in this study?\",\"answer\":\"The study reports that amplification of CSE1L enhances stemness of tumor-initiating cells, facilitates angiogenesis, and supports tumor formation. Experimental validation indicates CSE1L promotes ovarian cancer progression, migration, and proliferation.\"}]","Multi-omics analysis and experiments uncover the link between cancer intrinsic drivers, stemness, and immunotherapy in ovarian cancer with validation in a pan-cancer census | PDF",1790170985,45,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce075d64a69b98e80021533d127d0795.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/205b63b95dbf93c9fe5827173de00385.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/160e7730747ac8f4049cbc90dca8be6c.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22735d5ddc82e6fc4037af3d5bef4347.webp",980,1385]